跳至主要内容
临床试验/CTRI/2024/07/071522
CTRI/2024/07/071522尚未招募2 期

A comparative clinical study of the effect of Siravedh and Gudaharitaki in the management of Vatarakta w.s.r. to Gout

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients of classical sign and symptoms of Vatarakta (Gout)with serum uric acid level greater than 7mg/dl in males and 6mg/dl in females.
  • 2. Age 16 to 70 years, of either sex.
  • 3. Patients willing to undergo trial.

排除标准

  • 1. Not willing to undergo trial.
  • 2. Patients having other associated arthropathies.
  • 3. Patients taking modern medicines like uricosuric or xanthine oxidase inhibitors.
  • 4. Contraindication of Siravedh.
  • 5. Patients suffering from any bleeding disorders, pregnancy, anemia, uncontrolled diabetes mellitus will be excluded from the study.
  • 6. Existing or less than 2 weeks ago oral treatment with corticosteroids or colchicine

研究者

发起方
Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur

相似试验